Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis
Status:
Completed
Trial end date:
2018-04-28
Target enrollment:
Participant gender:
Summary
the study was conducted on 31-patients with symptomatic primary knee osteoarthritis. The
patients were randomized into intervention and control groups. The control group was kept on
their medications without intervention. The intervention group received two doses of
allogenic lyophilized growth factors (L-GFs); at baseline and after 2 months.